2025-06-13-花旗集团-泡泡玛特(9992)_全球观点_15页_1mb
报告摘要
The Global Point Summary
Core Content Overview
This document provides an analysis and investment recommendations from Citi Research for various global markets, focusing on stock ratings, target price changes, and key growth drivers for selected companies. The report covers Asia, CEEMEA, North America, Western Europe, and other regions, with a detailed evaluation of each company's performance, strategy, and market outlook.
Key Rating and Target Price Changes
| Region | Company | Rating | Target Price Change |
|---|---|---|---|
| Asia | Pop Mart (9992.HK) | Buy | ▲ (from 162 to 308) |
| Asia | Chow Tai Fook Jewellery Group (1929.HK) | Buy | ▲ (from 10.20 to 14.00) |
| Asia | Pharmaron (300759.SZ) | Buy | ▲ (from 26.64 to 30.00) |
| Asia | Tidlor Holdings (TIDLOR.BK) | Buy | ▲ (from na to 19.00) |
| Asia | Asclemis Pharma (1672.HK) | Buy | ▲ (from na to 20.00) |
| CEEMEA | Arcelik AS (ARCLK.IS) | Buy | ▲ (from Neutral to Buy) |
| North America | Chewy Inc (CHWY.N) | Buy | ▲ (from 42.00 to 49.00) |
| North America | Comstock Resources (CRK.N) | Neutral | ▲ (from 22.00 to 27.00) |
| North America | Kura Sushi (KRUS.O) | Neutral | ▲ (from 47.00 to 85.00) |
| Western Europe | SKF (SKFb.ST) | Neutral | ▲ (from na to 232.00) |
| Western Europe | Rentokil (RTO.L) | Buy | ▼ (from 5.50 to 4.70) |
| Japan | Cosmos Pharmaceutical (3349.T) | Buy | ▲ (from 9,500 to 11,200) |
| Japan | IHI (7013.T) | Buy | ▲ (from 16,000 to 19,000) |
| Japan | Shimamura (8227.T) | Buy | ▲ (from 10,100 to 12,000) |
| Latin America | JBS (JBSS32.SA) | Buy | ▲ (from 55.00 to 111.00) |
| Latin America | Hidrovias (HBSA3.SA) | Neutral | ▲ (from 3.00 to 3.60) |
Asia
Pop Mart (9992.HK)
- Rating: Buy
- Target Price: HK$308 (▲ from HK$162)
- Key Points:
- Strong IP influence and global recognition.
- New product rollouts (e.g., THE MONSTER Wacky Mart series) and themed pop-up stores as short-term growth catalysts.
- Diversified IP strategy supports long-term growth.
- Analyst: Lydia Ling
Chow Tai Fook Jewellery Group (1929.HK)
- Rating: Buy
- Target Price: HK$14.00 (▲ from HK$10.20)
- Key Points:
- FY25 results in line with expectations.
- Positive outlook on SSS recovery and re-rating potential with gold price fluctuations.
- Valuation attractive at 20% discount to historical P/E and 5.4% yield.
- Analyst: Tiffany Feng
CEEMEA
Arcelik AS (ARCLK.IS)
- Rating: Buy/HR
- Target Price: TL170 (▲ from Neutral)
- Key Points:
- EBITDA margins and consumer demand expected to recover.
- Cost optimization in European business and improved EUR/USD exchange rate.
- Positive outlook on rate cuts and operational leverage.
- Analyst: Maksim Nekrasov
North America
General Motors (GM.N)
- Rating: Buy
- Target Price: $59
- Key Points:
- Improved risk profile and lower breakeven level.
- Increased US light vehicle market share despite declining incentives.
- Potential for share repurchases in H225.
- Analyst: Michael Ward
North America Specialty Chemicals
- Downgrade SHW to Neutral due to sluggish housing market.
- RPM is highlighted as a top pick with better visibility into share gains and end-market strength.
- PPG Industries is recommended as a Buy with target price $130.
- Analyst: Patrick Cunningham
Western Europe
SKF (SKFb.ST)
- Rating: Neutral
- Target Price: SEK 232 (▲ from na)
- Key Points:
- Valuation fair against peers, but re-rating potential limited due to lack of strong growth and FCF drivers.
- Potential for share price upside if Automotive spin-off is completed.
- Analysts: Klas Bergelind | Siron Ng
Daimler Truck Holding AG (DTGGe.DE)
- CMD 2025 expected to be a turning point.
- Potential for EUR2bn buyback and improved profitability in MB.
- Analysts: Klas Bergelind | Siron Ng
Rentokil (RTO.L)
- Rating: Buy
- Target Price: £4.70 (▼ from £5.50)
- Key Points:
- Low expectations despite self-help initiatives.
- Analyst: Marc Van't Sant
DSM-Firmenich AG (DSFIR.AS)
- Rating: Buy
- Target Price: €140 (▲ from €135)
- Key Points:
- Potential to achieve lower end of EBITDA margin target.
- Market underestimates TTH segment.
- Analysts: Sebastian Satz, CFA | Ranulf Orr, CFA | Omi Pallavi
Investment Rating Definitions
- Buy: Expected total return (ETR) of 15% or more (25% for High Risk stocks).
- Neutral: ETR not meeting Buy or Sell criteria.
- Sell: Negative ETR.
- Catalyst Watch: Short-term share price movements expected due to specific events (e.g., mergers, product launches).
- Risk Rating: High risk stocks are highlighted based on price volatility and fundamental criteria.
Disclosure Notes
- The report may contain conflicts of interest due to Citi Research's business relationships.
- Recommendations are based on analyst expectations and are not guaranteed.
- The Firm may act as a liquidity provider or principal in transactions related to the recommended instruments.
- Analysts are certified for their recommendations and ensure independence in research preparation.
- Historical disclosures and recommendations can be accessed via Citi Velocity or the firm's disclosure website.
Summary of Key Investment Themes
- IP-driven growth: Pop Mart and Chow Tai Fook are highlighted for their IP strategy and potential for global expansion.
- AI integration: Ping An Good Doctor is noted for its AI family doctor services and improved user experience.
- Operational recovery: Arcelik and SKF are expected to benefit from cost optimization and margin recovery.
- Sector-specific trends: RPM is seen as a top pick in coatings due to its exposure to non-residential and infrastructure markets.
- Valuation opportunities: Tidlor Holdings and Siam Cement are identified as undervalued with strong upside potential.
- Macroeconomic headwinds: Thailand consumer finance faces challenges due to asset quality and loan growth, but some segments show early recovery.
Analysts and Their Focus
- Lydia Ling: Focuses on Pop Mart's IP growth and product rollouts.
- Tiffany Feng: Highlights Chow Tai Fook's recovery and re-rating potential.
- Maksim Nekrasov: Emphasizes Arcelik's recovery and margin improvement.
- Patrick Cunningham: Evaluates coatings sector with a focus on RPM and PPG.
- Marc Van't Sant: Reviews Rentokil's performance and market outlook.
- Sebastian Satz, CFA | Ranulf Orr, CFA | Omi Pallavi: Analyze DSM's operational performance and valuation potential.
- Klas Bergelind | Siron Ng: Discusses SKF's re-rating and Daimler Truck's CMD event.
Conclusion
The report outlines a mix of Buy, Neutral, and Sell recommendations across multiple regions, emphasizing IP growth, AI integration, operational improvements, and sector-specific opportunities. While some stocks face headwinds, others are positioned for recovery and re-rating. Analysts highlight the importance of short-term catalysts and long-term fundamentals in shaping investment decisions.
试读结束,高清完整版pdf/doc/ppt,请点下载